CTRI/2022/09/045611已完成4 期
Drug-Drug Interactions and Prescription Appropriateness in COVID-19 ICU Patients in a Tertiary Care Hospitalâ??
ESIC Medical College and Hospital0 个研究点目标入组 191 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 191
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Case record of all adult patients with proven diagnosis of SARS-CoV-2 infection (a throat swab positive for viral nucleic acid) admitted to the COVID-19 ICU during the study period and treated with at least two drugs will be considered.
排除标准
- •Patients transferred to other wards from ICU or discharged/death within 24hr of admission will be excluded.
研究者
相似试验
已完成
不适用
DRUG INTERACTION POTENTIAL BETWEEN trans-RESVERATROL AND SIMVASTATICTRI/2023/02/049518SRM COLLEGE OF PHARMACY , SRM INSTITUTE OF SCIENCE AND TECHNOLOGY20
尚未招募
不适用
Assessing Potential Drug- Drug Interactions with Integrase Inhibitors in HIV patients.CTRI/2022/02/040013Manipal Academy of Higher Education
已完成
不适用
A study to evaluate prescription pattern and monitorining of side effects related with drugs prescribed in patients with Rheumatoid ArthritisCTRI/2010/091/000550Maulana Azad Medical college200
已完成
不适用
A Drug-Drug Interaction, Safety and Efficacy Study With JNJ-56021927 (ARN-509) and Abiraterone Acetate in Subjects With Metastatic Castration-Resistant Prostate Cancer10036958prostate cancerNL-OMON44408Johnson & Johnson Pharmaceutical10
尚未招募
Unknown
Analysis of possible interactions between different drugs in older adult patients with chronic kidney diseaseCTRI/2024/08/072194Dr.Akshay Balakrishna